Learn More
Medchemexpress LLC Sulforaphane | 4478-93-7 | MFCD00016766 | 99.0% | 177.29 | 50 MG

Supplier: Medchemexpress LLC HY1375550MG
Sulforaphane is an orally active inducer of the Keap1/Nrf2/ARE pathway, promoting transcription of tumor-suppressing proteins and inhibiting HDACs. It protects the heart by activating the Keap1/Nrf2/ARE pathway and inducing HO-1 expression, and suppresses high glucose-induced pancreatic cancer via AMPK-dependent signal transmission. It exhibits both anticancer and anti-inflammatory properties.
- Induces cell cycle arrest and apoptosis.
- Inhibits growth re-initiation and decreases cell viability.
- Reduces apoptotic cells and pro-apoptotic proteins.
- Activates Keap1/Nrf2/ARE pathway and induces HO-1 expression.
- Inhibits mammary tumor formation.
- Reduces incidence and weight of DMBA-induced mammary tumors.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.